677 related articles for article (PubMed ID: 34716096)
1. Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel.
Ng KW; Faulkner N; Wrobel AG; Gamblin SJ; Kassiotis G
Semin Immunol; 2021 Jun; 55():101507. PubMed ID: 34716096
[TBL] [Abstract][Full Text] [Related]
2. Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.
Abela IA; Schwarzmüller M; Ulyte A; Radtke T; Haile SR; Ammann P; Raineri A; Rueegg S; Epp S; Berger C; Böni J; Manrique A; Audigé A; Huber M; Schreiber PW; Scheier T; Fehr J; Weber J; Rusert P; Günthard HF; Kouyos RD; Puhan MA; Kriemler S; Trkola A; Pasin C
mBio; 2024 Feb; 15(2):e0272223. PubMed ID: 38270455
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses.
Peng Y; Liu Y; Hu Y; Chang F; Wu Q; Yang J; Chen J; Teng S; Zhang J; He R; Wei Y; Bostina M; Luo T; Liu W; Qu X; Li YP
Front Immunol; 2022; 13():1056272. PubMed ID: 36618428
[TBL] [Abstract][Full Text] [Related]
4. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
[TBL] [Abstract][Full Text] [Related]
5. The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses.
Soni MK; Migliori E; Fu J; Assal A; Chan HT; Pan J; Khatiwada P; Ciubotariu R; May MS; Pereira MR; De Giorgi V; Sykes M; Mapara MY; Muranski PJ
Front Immunol; 2023; 14():1212203. PubMed ID: 37901229
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies.
Ng KW; Faulkner N; Finsterbusch K; Wu M; Harvey R; Hussain S; Greco M; Liu Y; Kjaer S; Swanton C; Gandhi S; Beale R; Gamblin SJ; Cherepanov P; McCauley J; Daniels R; Howell M; Arase H; Wack A; Bauer DLV; Kassiotis G
Sci Transl Med; 2022 Jul; 14(655):eabn3715. PubMed ID: 35895836
[TBL] [Abstract][Full Text] [Related]
7. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
Loos C; Atyeo C; Fischinger S; Burke J; Slein MD; Streeck H; Lauffenburger D; Ryan ET; Charles RC; Alter G
mSphere; 2020 Sep; 5(5):. PubMed ID: 32878931
[TBL] [Abstract][Full Text] [Related]
8. Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.
Wratil PR; Schmacke NA; Karakoc B; Dulovic A; Junker D; Becker M; Rothbauer U; Osterman A; Spaeth PM; Ruhle A; Gapp M; Schneider S; Muenchhoff M; Hellmuth JC; Scherer C; Mayerle J; Reincke M; Behr J; Kääb S; Zwissler B; von Bergwelt-Baildon M; Eberle J; Kaderali L; Schneiderhan-Marra N; Hornung V; Keppler OT
Cell Rep; 2021 Dec; 37(13):110169. PubMed ID: 34932974
[TBL] [Abstract][Full Text] [Related]
9. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
[TBL] [Abstract][Full Text] [Related]
10. Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2.
Denninger V; Xu CK; Meisl G; Morgunov AS; Fiedler S; Ilsley A; Emmenegger M; Malik AY; Piziorska MA; Schneider MM; Devenish SRA; Kosmoliaptsis V; Aguzzi A; Fiegler H; Knowles TPJ
ACS Infect Dis; 2022 Apr; 8(4):790-799. PubMed ID: 35352558
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19-convalescent individuals.
Li M; Liu J; Lu R; Zhang Y; Du M; Xing M; Wu Z; Kong X; Zhu Y; Zhou X; Hu L; Zhang C; Zhou D; Jin X
J Allergy Clin Immunol; 2022 Apr; 149(4):1225-1241. PubMed ID: 35074422
[TBL] [Abstract][Full Text] [Related]
12. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers.
Klompus S; Leviatan S; Vogl T; Mazor RD; Kalka IN; Stoler-Barak L; Nathan N; Peres A; Moss L; Godneva A; Kagan Ben Tikva S; Shinar E; Dvashi HC; Gabizon R; London N; Diskin R; Yaari G; Weinberger A; Shulman Z; Segal E
Sci Immunol; 2021 Jul; 6(61):. PubMed ID: 34326184
[TBL] [Abstract][Full Text] [Related]
14. Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study.
Sealy RE; Hurwitz JL
Microorganisms; 2021 Jul; 9(8):. PubMed ID: 34442723
[TBL] [Abstract][Full Text] [Related]
15. Pre-existing Immunity to Endemic Human Coronaviruses Does Not Affect the Immune Response to SARS-CoV-2 Spike in a Murine Vaccination Model.
Jeong AY; Lee P; Lee MS; Kim DJ
Immune Netw; 2023 Apr; 23(2):e19. PubMed ID: 37179748
[TBL] [Abstract][Full Text] [Related]
16. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
[TBL] [Abstract][Full Text] [Related]
17. Immune responses of lung transplant recipients against SARS-CoV-2 and common respiratory coronaviruses: Evidence for pre-existing cross-reactive immunity.
Bansal S; Fleming T; Canez J; Maine GN; Bharat A; Walia R; Tokman S; Smith MA; Tiffany B; Bremner RM; Mohanakumar T
Transpl Immunol; 2023 Dec; 81():101940. PubMed ID: 37866672
[TBL] [Abstract][Full Text] [Related]
18. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
[TBL] [Abstract][Full Text] [Related]
19. Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses.
McNaughton AL; Paton RS; Edmans M; Youngs J; Wellens J; Phalora P; Fyfe A; Belij-Rammerstorfer S; Bolton JS; Ball J; Carnell GW; Dejnirattisai W; Dold C; Eyre DW; Hopkins P; Howarth A; Kooblall K; Klim H; Leaver S; Lee LN; López-Camacho C; Lumley SF; Macallan DC; Mentzer AJ; Provine NM; Ratcliff J; Slon-Compos J; Skelly D; Stolle L; Supasa P; Temperton N; Walker C; Wang B; Wyncoll D; ; ; Simmonds P; Lambe T; Baillie JK; Semple MG; Openshaw PJ; ; Obolski U; Turner M; Carroll M; Mongkolsapaya J; Screaton G; Kennedy SH; Jarvis L; Barnes E; Dunachie S; Lourenço J; Matthews PC; Bicanic T; Klenerman P; Gupta S; Thompson CP
JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35608920
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2.
Bates TA; Weinstein JB; Farley S; Leier HC; Messer WB; Tafesse FG
Cell Rep; 2021 Feb; 34(7):108737. PubMed ID: 33545052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
